Journey Medical Corp Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 4.95M-43.99M-29.63M-3.85M-14.67M
Share-based Compensation 0.15M2.47M4.42M2.61M6.10M
Deferred Taxes -0.34M1.57M
Gains from Sales and Divestitures 0.14M0.29M0.73M1.06M
Gains from Investment Securities 0.11M0.16M0.17M0.18M0.12M
Asset Writedowns and Impairment 0.05M0.05M0.28M3.14M0.52M
Non-cash Items 7.93M9,661.39M2,217.82M3,441.15M6,191.99M
Cash from Operations 5.13M-2.18M-13.53M5.24M-9.13M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.42M2.57M4.28M3.77M3.42M
Amortization of Deferred Charges 0.70M0.78M0.77M0.35M
Depreciation & Amortization (CF) 0.01M
Change in Working Capital
Change in Receivables 5.02M-0.77M5.38M-12.55M-4.47M
Change in Inventory 0.55M8.46M-1.74M-3.95M4.22M
Change in Account Payables -0.20M20.39M14.34M-18.42M-2.10M
Change in Accured Expenses 2.39M1.24M-3.57M0.96M-2.92M
Change in Taxes 2.19M-0.09M0.03M0.02M0.01M
Other Working Capital Changes 1.01M0.77M0.87M0.28M-0.38M
Investing Activities
Capital Expenditures 7.87M20.00M5.00M15.00M
Change in Intangibles 1.20M10.00M
Cash from Investing Activities -1.20M-10.00M-20.00M-5.00M-15.00M
Financing Activities
Other financing activities 2.00M0.21M0.47M0.05M
Cash from Financing Activities -0.49M53.02M16.46M-4.80M16.99M
Additional items
Change in Cash 3.44M40.84M-17.08M-4.56M-7.13M
Beginning Cash Balance 4.80M8.27M49.08M32.00M27.44M
Free Cash Flow -2.74M-2.18M-33.53M0.24M-24.13M
Net Cash Flow 3.44M40.84M-17.08M-4.56M-7.13M